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Murine resistance to development of toxoplasmic encephalitis (TE) has recently been mapped 
to the D region of the major histocompatibility  complex (H-2). Since the gene for tumor necrosis 
factor o~ (TNF-o  0  is located 5' of the D  region and TNF-o~ has been implicated as playing a 
role in neurological diseases, we were interested in determining the relationship of TNF-ot production 
to TE resistance. We have demonstrated that resistance to TE in inbred mice can be correlated 
with specific restriction fragment length polymorphisms and microsateUite variants in the TNF-c~ 
gene. Mice that are susceptible to TE express elevated levels of TNF-ol mRNA in brain tissue 
6 wk after infection with the ME49 strain of Toxoplasma gondii.  Resistant mice and all mice 
that are uninfected show no detectable TNF-ol mRNA expression in brain tissue. Differences 
in the TNF-c~ gene between susceptible and resistant mice have been localized to the first intron, 
the promoter, and the 3' end of the TNF-o~ gene. These data implicate differences in regulation 
of TNF-o~ production in brain tissue as contributing to differences in susceptibility to development 
of TE. 
T 
he cytokine TNF-ol plays a fundamental role in immuno- 
logical responses  of host tissue to invading organisms 
and has been implicated in the pathogenesis of neurological 
diseases (1-3). Produced by astrocytes in brain tissue, TNF-o~ 
has been shown to cause demyelination of nerve fibers (4) 
in vitro and to exert cytotoxic effects on myelin-producing 
oligodendrocytes (5). In mice infected with Plasmodium  ber- 
ghei, TNF-ol appeared to play a role in the pathogenesis of 
cerebral malaria,  since antibodies to TNF-c~ fully protected 
mice against neurological manifestations and mortality (6). 
In vitro studies demonstrated that treatment of macrophages 
with TNF-c~ had no significant effect on inhibiting intracel- 
Mar replication of Toxoplasma gondii (7). Analyses of the in 
vivo role of TNF-ot during acute infection with T. gondii have 
yielded conflicting results. Repeated experiments in our lab- 
oratory have revealed earlier mortality after TNF-c~ treatment 
in Swiss Webster and BALB/c  mice (8; Orellana, M., and 
J. S. Remington, unpublished observations), whereas Chang 
et al.  (9) have found protection in Swiss Webster mice. 
The importance of toxoplasmic encephalitis (TE) 1 among 
AIDS patients has served as an impetus for studying the patho- 
genesis of TE. Suzuki et al. (10) have analyzed resistance to 
development of TE in a group of inbred mouse strains and 
localized genes that contribute to differences in resistance to 
the D region of the mouse MHC (H-2) (Table 1, first four 
columns). These authors and Brown and McLeod (11) also 
have reported on a correlation of the numbers of T. gondii 
cysts in brains of inbred strains of mice with the d haplotype 
at the D and L loci, respectively. Although it is not known 
whether the numbers of T. gondii cysts in the brain are related 
to development of TE, a number of investigators have impli- 
cated the cyst form in recrudescence of latent infection in the 
central nervous system (12, 13). The D  region of the H-2 
complex contains the genes for TNF-c~ and TNF-/~, at a dis- 
tance of ~70 kb from the D locus (14). Since RFLPs have 
1 Abbreviations  used in this t,  atx, r: TBE, Tris-borate-El3~; TE, toxoplasmic 
encephalitis. 
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associated with differences in levels of expression of TNF-cx 
protein (15), we investigated polymorphisms in this gene to 
determine whether these polymorphisms were associated with 
susceptibility or resistance  to development of TE. 
Materials and Methods 
Mice.  BALB/c  mice were obtained from Simonsen Laborato- 
ries (Gilroy,  CA), and CBA/Ca mice from Charles River Breeding 
Colony (Cambridge, MA) or from The Jackson Laboratory (Bar 
Harbor, ME). C57BL/10 and A/J mice were obtained from The 
Jackson Laboratory  and the B10.A recombinant  congenic mice were 
obtained through the courtesy of Dr. Timothy Poole of the Fox 
Chase Cancer Center (Philadelphia, PA). 
Southern Blot Analysis.  Genomic  DNA was isohted from spleens 
of seven inbred mouse strains and Southern blotting was carried 
out according to standard protocols (17). DNA was digested to 
completion with restriction enzymes, according  to supplier's recom- 
mendations, 10/~g of digested DNA was loaded per lane onto a 
0.8% agarose gel and subjected to electrophoresis in TBE. Elec- 
trophoresis was carried out for various lengths of time to optimize 
separation of RFLP fragments. DNA was transferred via southern 
blotting for '~18 h to Nytran membranes (Schleicher & Schuell, 
Inc., Keene, NH) and crosslinked using a UV Stratalinker (2400; 
Stratagene, San Diego, CA). Filters were prehybridized at 42~ 
in 5x  SSPE, 50% formamide, 5x  Denhardt's, 0.65% SDS, and 
100/~g/ml salmon sperm DNA, and hybridized to a 300-bp PvulI 
fragment encoding a portion of  the fourth exon of  the TNF-cx gene. 
This fragment was labded with 32p-dCTP by hexamer-priming 
(18) to a spedfic activity of 8-10  x  10  s cpm//zg, and filters were 
hybridized with 1-2.5  x  107 cpm per filter for 24 h. Filters were 
washed in 2x  SSC/0.1% SDS at room temperature and in 0.1x 
SSC/0.1% SDS at 60~  for 30 rain and 2 h, respectively.  Filters 
were exposed to XAR Kodak film for 48 h with two Cronex 
lightening-plus intensifying screens. 
Northern Blot Analysis.  2-mo-old female mice of the BALB/c, 
CBA/Ca, A/J, and C57BL/10 strains  were infected  intraperitoneally 
with 10 cysts of the ME49 strain of T. gondii in sterile, endotoxin- 
tested PBS (Sigma Chemical Co., St. Louis, MO). Control mice 
were injected  with endotoxin-tested  PBS. 6 wk after infection, mice 
were killed using CO2, and brains were processed according to the 
method of Chomczynski and Sacchi (19) to extract RNA. 100/~g 
of total RNA per lane was loaded onto a 1.5% agarose gd and 
subjected to dectrophoresis in lx MOPS buffer with 3% formal- 
dehyde (17). RNA was transferred to Nytran membranes, cross- 
linked as described above, and hybridized to the PvulI fragment 
of the murine TNF-cx probe as described. Filters were washed ac- 
cording to the manufacturer's recommendations and exposed to 
x-ray film as described. 
Oligonucleotides.  Oligonucleotides  were synthesized  on an DNA 
synthesizer (391; Applied Biosystems, Inc., Foster, City, CA) and 
then desalted by passing the samples through a Sephadex G-25 
column. Oligonucleotides  were end-hbeled using 10 pmol of  primer 
in a mixture containing 50 mM Tris-C1, pH 7.6, 10 mM MgC12, 
5 mM dithiothreitol,  0.1 mM spermidine-HC1, 0.1 mM EDTA, 
pH 8.0, 10 pmol 3,000 Ci/mmol y-[32p]ATP, and 2 U T4 poly- 
nucleotide kinase. 
Amplification of Microsatellites.  The oligonucleotides  flanking the 
mouse TNF-c~ promoter  (AC)n repeat that were used as PCR 
primers were: primer 1, GGACAGAGAAGAAAIGCa3TTC;  primer 
2, TCGAAI~~CAATCAGGAGGG. The oligonudeotides 
flanking the mouse HSP70 (TA)n repeat that were used as primers 
in  PCR  were: primer  1,  GTAATTGCGTTGACTGTTAAAT; 
primer 2, TCGAAGTGCTGCTCCCAACATTACT. 
PCRs were carried out in a total volume of 25/~1:100 ng mouse 
genomic DNA template, 100 ng cold primer 1, 1 ng 5' end-labeled 
primer 2, 0.4 mM each dATP, dCTP, cGTP, and dTTP, 10 mM 
Tris-C1, pH 8.3, 50 mM KC1, 1.5 mM MgC12, 0.01% gelatin, 0.5 
U AmpliTAQ  DNA polymerase  (Perkin-Elmer Cetus, Emeryville, 
CA). 30 cycles  of amplification  were performed with denaturation 
at 94~  (1 min), annealing at 55~  (1 rain), and elongation at 
72~  (1 min). The elongation step in the last cycle  was extended 
to 10 rain at 72~  Aliquots of amplified sample were analyzed 
on a denaturing 6% polyacrylamide  gel. Gels were dried and au- 
toradiographed with an intensifying screen. Fragment sizes were 
measured relative to a size standard consisting of DNA sequence 
ladders derived from bacteriophage M13mp18; the control DNA 
was supplied  in the sequenase kit (United States Biochemical  Corp., 
Cleveland, OH). 
Results and Discussion 
The presence of the d haplotype at the D locus of the H-2 
complex has been shown by Suzuki et al.  (10) to correlate 
with resistance  to development of TE and with absence of 
inflammation in brain tissue.  A/J, BALB/c,  and congenic 
B10.A(3K) and (18P,) mice, which express the d haplotype 
at the H-2 D locus, showed little inflammation in brain tissue 
after infection, whereas CBA/J, C57BL/6,  C57BL/10, and 
B10.A(4K) mice, which do not express the d haplotype at 
D, had remarkable meningeal and perivascular infiltration and 
loci of acute inflammation. 
Genomic  DNA  from  the  TE-resistant  BALB/c,  A/J, 
B10.A(3R),  and  B10.A(18R)  mice  and  from  susceptible 
CBA/Ca, C57BL/10, and B10.A(4R) mice was digested with 
BamHI or with XbaI, and Southern blots were probed with 
a PvulI fragment from the fourth exon of the TNF-c~ gene 
(Fig.  1, A  and B). When DNA was digested with BamHI, 
a 9-kb fragment was observed in TE-resistant BALB/c, A/J, 
B10.A(18R), and B10.A (3K) mice, whereas a 10.5-kb frag- 
ment was observed in susceptible  CBA/Ca, C57BL/10,  and 
B10.A(4K) mice. When DNA was digested with XbaI,  a 
6.3-kb fragment was generated in TE-susceptible CBA/Ca, 
C57BL/10,  and B10.A(4K)  mice,  and a  5.9-kb  fragment 
was generated in resistant BALB/c, A/J, B10.A (18R), and 
B10.A(3R) mice. The PvulI fragment, which was used as 
a probe, contained a HinclI restriction site. For this reason, 
double digestion with BamHI and HinclI was used to deter- 
mine whether the difference in BamHI digestion could be 
localized 5' or 3' of the fourth exon (Fig.  1 C). A 4.3-  or 
a 4.2-kb band was observed  in all mouse strains tested. We 
deduced from the location of the 5' BamHI site in the se- 
quence of Shakhov et al. (20) that these fragments covered 
the region 3' of the HinclI site in the fourth exon. The size 
of the fragment covering the 5' portions of the TNF-ol gene 
was 2.7 kb in susceptible strains and 1.2 kb in resistant strains. 
The 1.2-kb band would place the 5' BamHI site of resistant 
mouse strains in the first intron of the TNF-cx gene. When 
the first intron was analyzed using the sequence from C57BL/6 
(20),  a site that differed by one nucleotide from that of a 
684  TNF-c~  Polymorphisms  and Resistance to Toxoplasmic Encephalitis Figure 1.  RFLP patterns in the TNF-c~ gene in mouse strains that differ in resistance to TE. (A) DNA digested with BamHI. (B) DNA digested 
with XbaI. (C) DNA digested with BamHl and HinclI. (D) DNA digested with BamHI and XbaI. Gels in B, C, and D were subjected to electrophoresis 
for ~24 h to optimize separation of bands and allow increased accuracy of size determination. 
BamHI restriction  site (GGACCC rather than  GGATCC) 
was found at  1.2 kb from the HincII site. This  suggested 
that a point mutation may have occurred to generate this differ- 
ence between susceptible and resistant mice. Shirai et al. (21) 
have sequenced a murine TNF-ot gene from a mouse strain 
not designated  by the authors.  Analysis of this sequence re- 
vealed a BamHI site in the first intron at a location that cor- 
responded to the site noted in the C57BL/6 sequence. Com- 
parison  of the TNF-ot sequence from Shirai et al. (21) with 
that of the C57BL/6 revealed five other differences between 
the strains in the first intron.  It has been suggested  that in- 
trons may be involved in regulation of gene expression (22, 
23), and the role of intron 1 in regulation of TNF-ot expres- 
sion will be investigated. 
The location of the polymorphic XbaI site was also deter- 
mined using double digestion of  DNA with BamHI and XbaI. 
A 6.1-kb fragment was generated  in TE-susceptible  strains 
and a 4.2-kb fragment in resistant mouse strains. The 1.9-kb 
difference in size between these fragments  appears to be due 
to a shift in the BamHI site of resistant  mice 1.5 kb closer 
to the 3' XbaI site and an additional 400 bp difference, which 
is the result of a shift in the XbaI site of resistant mice 400 bp 
closer to the 5' end of the TNF-o~ gene. The region of differ- 
ences in XbaI restriction  sites is '~3.3 kb from the 3' end 
of the fourth exon  of the TNF-o~ gene. 
DNA polymorphisms with  only two alleles, as in  the 
TNF-o~ RFLPs, have a minimum polymorphic information 
content (PIC) value of  0.375 (24). On the other hand, DNA 
polymorphisms based on length variation in simple-sequence 
tandem repeats, called microsatellites,  have an average PIC 
value of  0.61, about twice the average for all two allele RFLPs 
(25). For this reason, we have utilized as a polymorphic marker 
an  (AC)n repeat  within  the  promoter  region  of TNF-cr. 
This (AC)n repeat is highly polymorphic (26, 27) and shows 
length variation  that correlates with resistance to TE (Fig. 
2 A, lanes I-4). Thus, the described correlation  of resistance 
685  Freund et al. Figure 2.  (.4) Size variability for the TNF-o~ (AC)~ 
microsatellite  repeat in selected  inbred and congenic mouse 
strains. Size differences  are resolved  on a DNA sequencing 
gel. Lane 1, A/J; lane 2, BALB/c; lane 3, B10.A(3R); 
lane 4, B10.A(18R); lane 5, CBA/J; lane 6, C57BL/6; 
lane 7, C57BL/10; and lane 8, B10,A(4R). (B) Distribu- 
tion of HSP70  (TA)n microsatellite  size variability  in 
selected inbred and congenic mouse strains. The (TA), 
repeat is located in the 3' untranslated region of an HSP70 
gene cloned by l.owe and Moran (29). The left four lanes 
are DNA sequencing ladders prepared from a template 
of known sequence. Lane I, C57BL/6; lane 2, C57BL/10; 
lane 3, B10.A(4R); lane 4, B10.A(18R); lane 5, BALB/c; 
lane 6, A/J; lane 7, CBA/J; and lane 8, B10.A(3R). 
to TE with the d haplotype in the D region is also a correla- 
tion with an RFLP in the first intron and with the (AC), 
microsatellite pattern in the promoter of the TNF-ol gene. 
In a further attempt to map murine resistance to TE, we 
have utilized an additional polymorphic microsatellite marker. 
The  3'  untranslated region of a  heat  shock protein  gene 
(HSP70),  located centromeric to the TNF-c~ gene (27), con- 
tains  a  (TA)n microsatellite.  This  microsatellite is  highly 
Table  1.  Mapping  the Murine  Susceptibility to  Toxoplasmic Encephalitis to  the  Central Portion of the 1-1-2 Complex 
H-2 haplotype  H-2  haplotype in D  region 
Inflammation  No.  of cysts/coronal 
Strain  K  A  E  S  D  in brain*  section of brain#  S  HSP70  s  TNF  D 
A/J  k  k  k  d  d  -  low  d  d  d  d 
BALB/c  d  d  d  d  d  -  low  d  d  d  d 
CBA/J  k  k  k  k  k  +  high  k  d  k  k 
C57BL6  b  b  b  b  b  +  high  b  b  b  b 
B10.A(3R)  b  b  k  d  d  -  low  d  aq  d  d 
B10.A(4R)  k  k  b  b  b  +  high  b  b  b  b 
B10.A(18tL)  b  b  b  b  d  -  low  b  b  d  d 
The first four columns are adapted from  Suzuki et al.  (10). 
* Mice were injected intraperitoneally with 10 cysts of the ME49 strain of T. gondii. 10 wk after infection, mice were killed and histological studies 
were carried out. Three to six mice were used in each experimental group. Positive inflammation: meningeal and perivascular  infiltration of mononuchar 
cells and acute loci of inflammation  in the tissue. 
* Low  =  <1.0; high  =  10-20 cysts. 
s The HSP70 and TNF-c~ haplotype designations are based on size variation in tandem repeats within the 5' or 3' untranslated  region of HSP70 
and the 5' regulatory  region of TNF-c*. The mapping of one member of the HSP70 family of genes is from Jacob and Hwang (27). 
686  TNF-c~  Polymorphisms and Resistance to Toxoplasmic Encephalitis Figure 3.  Northern blot analysis  of total RNA from brain tissue of 
mice  infected  intraperitoneaUy  with 10 cysts  of  the ME49 strain  of T.  gondii. 
RNA was extracted 6 wk after infection. 100 #g RNA was loaded in 
each lane. Blot was probed with a 300-bp PvuU fragment  from exon 4 
of the TNF-~ gene. 
polymorphic and shows different size variants in the relevant 
strains of mice (Fig. 2 B).  Using the three B10.A congenic 
mouse strains, we can clearly map resistance to TE tellomeric 
to HSP70 (Table 1). 
To determine whether the observed RFLPs in the TNF-cr 
gene correlated with expression of TNF-c~ transcripts during 
TE, mice from two susceptible and two resistant strains were 
infected with the ME49 strains and KNA was isolated from 
brain tissue at 6 wk after infection. In Fig. 3, Northern blot 
analysis of total KNA revealed that mKNA for TNF-cz was 
detectable only in susceptible  CBA/Ca and C57BL/10 mice 
that had been infected with ME49. No RNA was detectable 
in brains of infected, TE-resistant BALB/c or A/J mice, nor 
in brains from uninfected control mice, which were injected 
with sterile PBS. The fact that no detectable TNF-c~ mKNA 
was expressed  in uninfected brain tissue suggested that the 
gene was regulated in part through an increase in transcrip- 
tion. We have preliminary evidence, using immtmohistochem- 
ical staining of fixed brain tissue,  that TNF-ol protein is ex- 
pressed in brains of infected CBA/Ca mice but not detected 
in infected BALB/c mice, nor in uninfected mice of either 
strain (data not shown). 
Strain-specific differences in regulation of TNF-c~ expres- 
sion in brain tissue have been observed in inbred rats (28), 
and high levels of TNF-cr  protein expression in CBA/Ca, 
but not BALB/c mice have been linked to susceptibility to 
cerebral malaria (6). Although it is possible  that expression 
of TNF-c~ in brains of susceptible  mice is just one aspect of 
the general inflammatory response that occurs during TE, 
the fact that TNF-ot has been demonstrated to play roles both 
in protection and pathology in other neurological diseases 
suggests that this cytokine warrants further study to deter- 
mine how its expression in brain tissue from TE-susceptible 
mice influences  the course of disease. 
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